Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Chemistry
Emerging Technology
Immunoassays
Molecular Diagnostics
Pathology & AI
Biomarker Discovery & Validation
Owlstone, FDA's OSEL partner to develop VOC ID methods
By
LabPulse.com staff writers
Owlstone Medical entered a research collaboration agreement with the FDA's Center for Devices and Radiological Health Office of Science and Engineering Laboratories (OSEL) to develop methods of identifying volatile organic compounds (VOCs) in breath.
September 30, 2024
Rapid diagnostic test developed for ALS
By
LabPulse.com staff writers
A blood diagnostic test for amyotrophic lateral sclerosis (ALS) has been developed that can rapidly distinguish ALS from conditions that mimic ALS in its early stages with a high level of specificity and sensitivity.
September 13, 2024
Analysis: Biomarker testing and targeted therapy underutilized in U.S. NSCLC patients
By
LabPulse.com staff writers
Biomarker testing and targeted therapy is significantly underused for patients with non-small cell lung cancer (NSCLC) in the U.S., according to an analysis of point-of-care real-world data conducted by Amplity Health.
June 10, 2024
FDA clears another blood-based TBI POC test
By
LabPulse.com staff writers
Abbott furthers its point-of-care (POC) assay for measuring traumatic brain injury biomarkers from whole blood.
April 1, 2024
Researchers map protein biomarkers in sepsis fight
By
Liz Carey
Swedish researchers are mapping patterns of protein biomarkers in sepsis that could be useful for simple blood tests in the emergency department, according to research to be presented at ECCMID 2024.
April 2, 2024
Two new directions in Parkinson’s testing
By
Liz Carey
Two recent Parkinson’s announcements suggest a new biomarker test panel coming, as well as cell culture systems for studying Parkinson’s in the laboratory.
December 11, 2023
Study: Blood test improves bipolar disorder diagnosis through biomarkers
By
Matt Limb
Diagnosis of bipolar disorder could be improved using a simple blood test to identify biomarkers associated with the condition, say researchers.
November 2, 2023
Researchers develop nanopore sequencing method for mapping disease biomarkers
By
Matt Limb
A nanopore sequencing method that can map dozens of biomarkers at the same time has the potential to transform testing for heart disease and other conditions, say researchers.
October 11, 2023
Quest Diagnostics teams up with Envision Science on prostate cancer biomarkers
By
Matt Limb
The test aims to improve the accuracy of grading biopsies for prostate cancer, which is one of the most prevalent and deadly cancers affecting men.
July 27, 2023
Physicians advocate for ‘careful’ use of osteoporosis bone turnover marker testing
By
Nick Paul Taylor
Knowing the rate of bone matrix removal or deposition can help physicians understand if a patient is at risk of fractures or is responding to treatment.
July 24, 2023
Quest launches biomarker test to improve grading of prostate cancer biopsies
By
Nick Paul Taylor
Building on the Australian research and working with Envision Sciences, the Australian diagnostics company that owns the biomarker intellectual property, Quest’s subspecialty pathology business, AmeriPath, has developed a tissue-based test.
July 17, 2023
DiamiR Biosciences partners with JADBio on diagnostic tests, validation for biomarker panels
By
Matt Limb
Under the deal, DiamiR will apply the capabilities of JADBio’s Automated Machine Learning (AutoML) bioinformatics platform and services to its own microRNA platform.
July 12, 2023
Page 1 of 5
Next Page